Enanta Pharma Q4 EPS $(1.36) Down From $(1.33) YoY, Sales $14.61M Down From $18.93M YoY

Benzinga · 11/25 21:15
Enanta Pharma (NASDAQ:ENTA) reported quarterly losses of $(1.36) per share. This is a 2.26 percent decrease over losses of $(1.33) per share from the same period last year. The company reported $14.61 million in sales this quarter. This is a 22.84 percent decrease over sales of $18.93 million the same period last year.